Free Trial
NASDAQ:VIRI

Virios Therapeutics (VIRI) Stock Price, News & Analysis

Virios Therapeutics logo
$4.95 +0.18 (+3.77%)
As of 07/1/2025

About Virios Therapeutics Stock (NASDAQ:VIRI)

Key Stats

Today's Range
$4.75
$5.00
50-Day Range
$4.52
$5.87
52-Week Range
$0.13
$1.04
Volume
25,682 shs
Average Volume
1.05 million shs
Market Capitalization
$95.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00
Consensus Rating
Hold

Company Overview

Receive VIRI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Virios Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

VIRI Stock News Headlines

Dogwood Therapeutics Inc (DWTX)
Dogwood prices 578,950 shares at $8.26 in registered direct offering
Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
Dogwood announces conversion of existing $19.5M in debt to equity
DWTX Stock trading resumes
Dogwood Therapeutics, Inc. (DWTX)
DWTX Stock trading halted, volatility trading pause
See More Headlines

VIRI Stock Analysis - Frequently Asked Questions

Virios Therapeutics' stock was trading at $2.49 at the beginning of the year. Since then, VIRI stock has increased by 98.8% and is now trading at $4.95.
View the best growth stocks for 2025 here
.

Virios Therapeutics, Inc. (NASDAQ:VIRI) released its earnings results on Thursday, August, 8th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.02.

Virios Therapeutics (VIRI) raised $30 million in an initial public offering on Thursday, December 17th 2020. The company issued 3,000,000 shares at a price of $9.00-$11.00 per share. ThinkEquity (a division of Fordham Financial Management) acted as the underwriter for the IPO.

Shares of VIRI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Virios Therapeutics investors own include Meta Platforms (META), AMC Entertainment (AMC), SNDL (SNDL), CISO Global (CISO), Canoo (GOEV), Mullen Automotive (MULN) and Organigram Global (OGI).

Company Calendar

Last Earnings
8/08/2024
Today
7/02/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VIRI
Fax
N/A
Employees
5
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.00
High Stock Price Target
$5.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+1.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$5.30 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.20 per share
Price / Book
24.75

Miscellaneous

Free Float
16,909,000
Market Cap
$95.33 million
Optionable
Optionable
Beta
1.58
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:VIRI) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners